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Risk factors for high cerebral blood flow velocity and death in
Kenyan children with Sickle Cell Anaemia: role of haemoglobin
oxygen saturation and febrile illness
An estimated 230 000 children are born in Africa each year
with Sickle Cell Anaemia (SCA) with high reported mortality
due to malaria, bacterial infections and anaemia (Fleming,
1989) but no African country in has an established national
management policy. Neurological complications are a signif-
icant cause of morbidity and mortality. Reports suggest that
the incidence of stroke in SCA patients in Africa is as high as
1Æ3/100 patient years (Izuora et al, 1989; Amayo et al, 1992)
compared with 0Æ61/100 patient years in the USA (Ohene-
Frempong et al, 1998), possibly due to higher prevalences of
the key risk factors (low haemoglobin, high white cell count,
Bantu haplotype) (Ohene-Frempong et al, 1998). Abnormal
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Summary
High cerebral blood flow velocity (CBFv) and low haemoglobin oxygen
saturation (SpO2) predict neurological complications in sickle cell anaemia
(SCA) but any association is unclear. In a cross-sectional study of 105 Kenyan
children, mean CBFv was 120 ± 34Æ9 cm/s; 3 had conditional CBFv (170–
199 cm/s) but none had abnormal CBFv (>200 cm/s). After adjustment for
age and haematocrit, CBFv ‡150 cm/s was predicted by SpO2 £ 95% and
history of fever. Four years later, 10 children were lost to follow-up, none had
suffered neurological events and 11/95 (12%) had died, predicted by history
of fever but not low SpO2. Natural history of SCA in Africa may be different
from North America and Europe.
Keywords: Sickle Cell Anaemia, Africa, transcranial Doppler ultrasound,
mortality, cerebrovascular accidents.
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and conditional cerebral blood flow velocity (CBFv) >200 cm/s
and 170–199 cm/s respectively, measured by transcranial
Doppler (TCD) ultrasonography of the intracerebral arteries,
respectively, predicted 40% and 7% risk of stroke over the
subsequent three years (Adams et al, 1992; Kirkham et al,
2001) while CBFv > 150 cm/s may indicate intracranial vessel
stenosis (Adams et al, 1990). Peripheral haemoglobin oxygen
saturation (SpO2) is also a predictor of overt stroke (Kirkham
et al, 2001; Quinn & Sargent, 2008) and might also predict
death, since it is associated with pulmonary hypertension
(Minniti et al, 2009). There has been no previous description
of CBFv or SpO2 in African SCA patients, their predictors or
their use for identifying those at high risk of adverse outcomes.
In this report we describe the spectrum of CBFv in a Kenyan
paediatric SCA cohort, exploring factors associated with high
CBFv and relating these data to mortality.
Study design
The study started in 2002 in Kilifi District Hospital (KDH),
following approval by the Kenya National Ethical committee.
There is a dedicated outpatient clinic for all SCA patients, seen
every 3–4 months after clinical diagnosis as there is no newborn
screening. Proguanil is given as antimalarial prophylaxis but
none of the patients are treated with penicillin prophylaxis or
Hydroxycarbamide. Study patients were recruited when well.
Following informed consent, history of clinical events, such as
febrile illness and episodes of neurological compromise includ-
ing seizures, was obtained, systematic general and neurological
examination conducted and daytime SpO2 (pulse oximetry;
Nellcor, Pleasanton, CA, USA) measured. Laboratory investi-
gations included blood count (MDII; Beckman Coulter,
Fullerton, CA, USA) and sickle genotype confirmed by alkaline
haemoglobin electrophoresis (Helena, Sunderland, Tyne &
Wear, UK). All information was collected in standardized
clinical research forms. Patients were followed up to November
2006 through clinic visits, with admissions, neurological events
and deaths captured by active surveillance.
CBFv was measured following the STOP (Stroke prevention in
sickle cell disease) protocol (Nichols et al, 2001) using the
Companion II (Nicolet, Warwick, UK) machine. The highest
CBFv (time-averagedmaximalmean velocity in the distal internal
carotid artery and middle cerebral artery on either side) was
determined. CBFv was classified as low (<50 cm/s), normal (50–
149 cm/s) or high (‡150 cm/s) based onprevious criteria (Adams
et al, 1990) and our Kenyan control data (Newton et al, 1996).
STATA 9 (StataCorp, College Station, TX, USA) was used
for statistical analysis. Continuous variables were analysed
using two-sided t-tests. Categorical variables were analysed by
chi-squared test. Logistic regression was used to explore
associations between CBFv and clinical and laboratory vari-
ables, presenting the results as odds ratio (OR) with 95%
confidence interval (CI). P-values <0Æ05 were considered
statistically significant. Multivariate analysis included all vari-
ables with univariate significance of <0Æ1. Using backward
elimination, the final model included all variables significant at
the 0Æ05 level. Binary logistic regression was also used to assess
factors predicting death (as date of death was not known).
Results
In 2002, 105 children with SCA (mean ± SD 7Æ4 ± 4Æ0 years)
had TCDmeasurements, with amean CBFv of 120 ± 34Æ9 cm/s.
Seven (7%) SCA patients had low, 80 (76%) normal and 18
(17%) high CBFv. Only 3 (3%) patients had conditional CBFv
(170–199 cm/s) andnonehadabnormallyhighCBFv(>200 cm/s).
The age group with the greatest prevalence of high CBFv was
5–9 years. Thirteen patients (12Æ4%) had a history of non-febrile
convulsions (2 high CBFv, 1 low CBFv), while only one patient
(normal CBFv) had a history of stroke. Children with previous
neurological complications did not have lower haematocrit
(P = 0Æ94) or SpO2 (P = 0Æ45) or higher CBFv (P = 0Æ87).
Patients with high CBFv were significantly more anaemic
(haematocrit 22Æ9 ± 4Æ8% vs. 25Æ5 ± 4Æ3%, P = 0Æ04) with
lower mean SpO2 (97 ± 2Æ97% vs. 98Æ5 ± 2Æ39%, P = 0Æ04)
compared to the normal CBFv group (Table I). There was a
trend for ‡3 reported febrile episodes in the past year to be
associated with high CBFv (P = 0Æ08; Table I). Multivariate
analysis using a model that included age and haematocrit
showed that SpO2 £ 95% (P = 0Æ02) and history of fever were
associated with high CBFv, with the likelihood of having high
CBFv increasing with the number of episodes of reported fever
(OR 13Æ8; P = 0Æ01 for ‡3 reported febrile episodes; Table I).
By 2006, 10 were lost to follow-up, none of whom had a high
baseline CBFv or SpO2 £ 95%. For the 95 childrenwith available
data (Table II) none had suffered neurological complications
but eleven (12%) had died. There was no significant difference in
mortality between those with normal or low CBFv, compared to
those with high CBFv (20 vs. 9%; P = 0Æ38). In univariate
analysis, history of febrile illness (P = 0Æ02) at baseline and blood
transfusion (P = 0Æ04) during follow-up were associated with
increased risk of death. Although not statistically significant,
survivors had a higher haemoglobin and CBFv, but a para-
doxically lower SpO2, at baseline. History of febrile illness and
blood transfusion were not predictors of death in a multi-
variate model that also contained peripheral SpO2 (Table II).
Discussion
This is the first description of CBFv in African SCA children. The
lower mean value for CBFv (120 vs. 129 cm/s) and absence of
abnormal CBFv, in contrast to the 3–10% prevalence in the USA
(Adams et al, 1992), are surprising, given the reportedly higher
incidence of stroke in Africa. This may be due to rapid
progression of disease, with death swiftly following the devel-
opment of high CBFv in young children, although we found no
evidence for any link betweenCBFv andmortality. In addition to
the possibility of an alternativemechanism, such as venous sinus
thrombosis, neurological complications inAfrican childrenwith
SCAmay be secondary to progressively worsening stenosis, with
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decrease in CBFv and sometimes moyamoya collaterals (Hogan
et al, 2005). In our study, low CBFv compatible with, but not
diagnostic of, moyamoya (Takase et al, 1997) was documented
in seven SCA patients, one of whom had had convulsions; none
of these patients was known to have died or have neurological
complications 4 years later.
In univariate analysis, patients with high CBFv had lower
haematocrit and oxygen saturation and were more likely to have
had ‡3 febrile episodes; however on multivariate analysis, only
the latter two factors were independently associated with high
CBFv. Recent evidence suggests that low oxygen saturation pre-
dicts neurological events (Kirkham et al, 2001; Quinn & Sargent,
2008); this might in part be explained by an association between
low SpO2 and high CBFv but any link to stroke risk cannot be
ascertained from our data in view of the low prevalence of
conditional or abnormalCBFvand the lackof neurological events.
Table II. Factors associated with death in SCA
patients in Kenya. Patients who
Survived
(n = 84)
Patients who
died (n = 11)
Odds Ratio
(95%CI) P
Mean Age, years (SD) 7Æ35 (4Æ1) 6Æ8 (4Æ4) 0Æ97 (0Æ83–1Æ13) 0Æ69
History of fever (Yes/No), n (%) 34 (41) 9 (82) 6Æ62 (1Æ34–32Æ54) 0Æ02
History of blood transfusion, n (%) 10 (12) 4 (36) 4Æ23 (1Æ04–17Æ1) 0Æ04
Mean Peripheral SpO2, % (SD) 98 (2Æ7) 99Æ6 (0Æ8) 2Æ07 (0Æ94–4Æ57) 0Æ07
Mean Haematocrit, % (SD) 24Æ9 (4Æ29) 23Æ6 (3Æ5) 0Æ92 (0Æ77–1Æ09) 0Æ34
High CBFv (‡150 cm/s), n (%) 17 (20) 1 (9) 0Æ39 (0Æ05–3Æ29) 0Æ38
Mean CBFv, cm/s (SD) 118Æ8 (34Æ4) 117Æ8 (23Æ1) 0Æ99 (0Æ98–1Æ02) 0Æ93
Multivariable analysis*
History of fever (Yes/No) 3Æ43 (0Æ65–18Æ07) 0Æ15
History of blood transfusion 2Æ80 (0Æ62–12Æ66) 0Æ18
Peripheral SpO2 (%) 1Æ90 (0Æ86–4Æ20) 0Æ11
[Mean (SD)] Geometric mean, standard deviation in parenthesis.
Prevalence of patients in the respective groups.
Odds ratio [95% Confidence Intervals (95% CI)] and P-value to show the association between
the respective factor and death.
*Fourteen children were excluded from the multivariate analysis of death due to missing data.
Peripheral oxygen saturation was used as a continuous variable as none of the children who died
had SpO2 <95%.
Table I. Factors associated with high CBFv
(‡150 cm/s) in SCA patients in Kenya. Normal or
low CBFv
(n = 87)
High CBFv
(n = 18)
Odds ratio
(95%CI) P
Mean Age, years (SD) 7Æ6 (4Æ3) 6Æ5 (2Æ7) 0Æ93 (0Æ82–1Æ06) 0Æ31
History of fever in past year, n (%) 40 (46) 8 (44)
1 episode of fever 34 (39) 4 (22) 0Æ55 (0Æ16–1Æ91) 0Æ35
2 episodes of fever 3 (3) 1 (6) 1Æ57 (0Æ15–16Æ66) 0Æ71
3 or more episodes of fever 3 (3) 3 (17) 4Æ7 (0Æ83–26Æ77) 0Æ08
History of chest events, n (%) 19 (22) 3 (17) 0Æ83 (0Æ38–1Æ79) 0Æ63
Mean Peripheral SpO2, % (SD) 98Æ5 (2Æ39) 97 (2Æ97) 0Æ83 (0Æ69–1Æ01) 0Æ04
Peripheral SpO2 £ 95%, n (%) 6 (8) 4 (31) 5Æ48 (1Æ29–23Æ18) 0Æ02
Mean Haematocrit, % (SD) 25Æ5 (4Æ33) 22Æ9 (4Æ79) 0Æ85 (0Æ73–0Æ99) 0Æ04
Multivariate analysis
Age, years 0Æ97 (0Æ81–1Æ15) 0Æ71
1 episode of fever in past year 1Æ1 (0Æ24–5Æ03) 0Æ90
2 episodes of fever in past year 1Æ87 (0Æ12–29Æ1) 0Æ66
3 or more episodes of fever in
past year
13Æ8 (1Æ72–111Æ2) 0Æ01
Haematocrit, % 0Æ92 (0Æ77–1Æ09) 0Æ34
Peripheral SpO2 £ 95% 6Æ13 (1Æ27–29Æ5) 0Æ02
[Mean (SD)] Geometric mean, standard deviation in parenthesis.
Prevalence of patients in the respective groups.
Odds ratio [95% Confidence Intervals (95% CI)] and P-value to show the association between
the respective factor and high CBFv.
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Although not statistically significant, those who died had a
higher SpO2 at baseline. In studies in the USA, low SpO2 is
associated with pulmonary hypertension, a predictor of death
in adults, but these relatively young Kenyan children may not
have yet developed this chronic complication (Minniti et al,
2009). Variation in exposure and adaptation to anaemic and
hypoxic hypoxia may explain some of the phenotypic
variability in SCA (Kirkham & Datta, 2006).
We report an association between parental report of ‡3
febrile illnesses in the past year and high CBFv, independent of
age, haematocrit and SpO2. Mortality was also predicted by
previous febrile illness. However, cause of death was not
recorded so we cannot infer any direct link with infection or
exclude neurological causes. The majority of SCD patients do
not currently receive penicillin prophylaxis in most African
countries, as there are conflicting data regarding the impor-
tance of infection, particularly streptococcal septicaemia, as a
cause of morbidity and mortality (Makani et al, 2007).
Assuming that febrile illness is commonly associated with
infection, it is important to determine the causal agent(s) so
that preventative strategies can be evaluated in this setting.
Given that this was a cross-sectional study conducted in
2002, with historical data about CNS events and febrile
episodes and limited information available from clinical review
and surveillance up to 2006, it is difficult to accurately
determine the cause-effect relationship of the various factors
and their change over time. Larger longitudinal population-
based birth cohorts, with repeated laboratory measurements,
such as CBFv and SpO2, and details of acute illness and clinical
events before death, are required to identify risk factors and
document the natural history of SCA in Africa.
This study shows a novel association between low SpO2 and
increased CBFv, which should be explored in non-African
settings. The absence of documented abnormally high CBFv
suggests that the course and mechanism of cerebral vasculo-
pathy and neurological events in Africa are different from
those in North America and Europe. More detailed neuroi-
maging studies with magnetic resonance angiography are
required to elucidate this further.
Acknowledgements
We thank the patients and staff of KDH and KEMRI – Centre
for Geographic Medicine Research (Coast).
Conflict of interest
The authors declare no competing financial or other interests.
Funding
This work was supported by the Wellcome Trust, UK (072064)
and Kenya Medical Research Institute (KEMRI) – Centre for
Geographic Medicine Research (Coast). Dr Kirkham was
funded by the National Heart Lung and Blood Institute
(#5-RO1-HL079937).
References
Adams, R.J., Nichols, III, F.T., Aaslid, R., McKie, V.C., McKie, K., Carl,
E., Stephens, S., Thompson, W.O., Milner, P. & Figueroa, R. (1990)
Cerebral vessel stenosis in sickle cell disease: criteria for detection by
transcranial Doppler. American Journal of Pediatric Hematology and
Oncology, 12, 277–282.
Adams, R., McKie, V., Nichols, F., Carl, E., Zhang, D., McKie, K.,
Figueroa, R., Litaker, M., Thompson, W. & Hess, D. (1992) The use
of transcranial ultrasonography to predict stroke in sickle cell dis-
ease. New England Journal of Medicine, 326, 605–610.
Amayo, E.O., Owade, J.N., Aluoch, J.R. & Njeru, E.K. (1992)
Neurological complications of sickle cell anaemia at KNH: a five
year retrospective study. East African Medical Journal, 69, 660–
662.
Fleming, A.F. (1989) The presentation, management and prevention of
crisis in sickle cell disease in Africa. Blood Reviews, 3, 18–28.
Hogan, A.M., Kirkham, F.J., Isaacs, E.B., Wade, A.M. & Vargha-Kha-
dem, F. (2005) Intellectual decline in children with moyamoya and
sickle cell anaemia. Developmental Medicine and Child Neurology, 47,
824–829.
Izuora, G.I., Kaine, W.N. & Emodi, I. (1989) Neurological disorders in
Nigerian children with homozygous sickle cell anaemia. East African
Medical Journal, 66, 653–657.
Kirkham, F.J. & Datta, A.K. (2006) Hypoxic adaptation during
development: relation to pattern of neurological presentation and
cognitive disability. Developmental Science, 9, 411–427.
Kirkham, F.J., Hewes, D.K., Prengler, M., Wade, A., Lane, R. & Evans,
J.P. (2001) Nocturnal hypoxaemia and central-nervous-system
events in sickle-cell disease. Lancet, 357, 1656–1659.
Makani, J., Williams, T.N. & Marsh, K. (2007) Sickle cell disease in
Africa: burden and research priorities. Annals of Tropical Medicine
and Parasitology, 101, 3–14.
Minniti, C.P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N.,
Onyekwere, O., Nouraie, M., Kato, G.J., Gladwin, M.T., Castro, O.L.
& Gordeuk, V.R. (2009) Elevated tricuspid regurgitant jet velocity in
children and adolescents with sickle cell disease: association with
hemolysis and hemoglobin oxygen desaturation. Haematologica, 94,
340–347.
Newton, C.R., Marsh, K., Peshu, N. & Kirkham, F.J. (1996) Pertur-
bations of cerebral hemodynamics in Kenyans with cerebral malaria.
Pediatric Neurology, 15, 41–49.
Nichols, F.T., Jones, A.M. & Adams, R.J. (2001) Stroke prevention in
sickle cell disease (STOP) study guidelines for transcranial Doppler
testing. Journal of Neuroimaging, 11, 354–362.
Ohene-Frempong, K., Weiner, S.J., Sleeper, L.A., Miller, S.T., Embury,
S., Moohr, J.W., Wethers, D.L., Pegelow, C.H. & Gill, F.M. (1998)
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
Blood, 91, 288–294.
Quinn, C.T. & Sargent, J.W. (2008) Daytime steady-state haemoglobin
desaturation is a risk factor for overt stroke in children with sickle
cell anaemia. British Journal of Haematology, 140, 336–339.
Takase, K., Kashihara, M. & Hashimoto, T. (1997) Transcranial
Doppler ultrasonography in patients with moyamoya disease.
Clinical Neurology and Neurosurgery, 99(Suppl 2), S101–S105.
Short Report
ª 2009 The Authors
532 Journal Compilation ª 2009 Blackwell Publishing Ltd, British Journal of Haematology, 145, 529–532
